is being cold a side effect of tirzepatide Feeling on Semaglutide and Why am I cold on

Photo by Rebecca Noble/Getty Images

The semaglutide API segment is projected to grow at 16.2% CAGR through 2034, compared to an estimated 11.5% CAGR for the broader GLP-1 API market excluding semaglutide, as semaglutide gains additional market share from older GLP-1 agents and potentially from tirzepatide in indications where semaglutide maintains formulary advantages

Chronic Weight Management : Semaglutide is also approved under the brand name Wegovy for adults with obesity or those who are overweight with at least one weight-related health condition, such as high blood pressure or high cholesterol

the peak response was at 120 min

Semaglutide has been shown to promote significant weight loss, improve glycemic control in people with type 2 diabetes, and reduce the risk of cardiovascular disease